Yvette Van Kooyk

Title: Yvette Van Kooyk: Innovator in Immunology

Introduction

Yvette Van Kooyk is a prominent inventor based in Arnhem, Netherlands. She has made significant contributions to the field of immunology, particularly in the modulation of immune responses. With a total of 4 patents, her work focuses on innovative methods to influence dendritic cell-T cell interactions.

Latest Patents

One of her latest patents is titled "Composition and method for modulating dendritic cell-T cell interaction." This invention relates to the use of a compound that binds to a C-type lectin on the surface of a dendritic cell. The composition is designed to modulate, particularly reduce, the immune response in animals, including humans. It specifically targets the interactions between dendritic cells and T-cells, focusing on the binding of a C-type lectin to an ICAM receptor on T-cells. The applications of this composition include preventing or inhibiting immune responses to specific antigens, inducing tolerance, immunotherapy, immunosuppression, and treating autoimmune diseases and allergies. The compounds used in this invention can include mannose, fucose, plant lectins, antibiotics, sugars, proteins, or antibodies against C-type lectins.

Career Highlights

Yvette Van Kooyk is affiliated with Katholieke Universiteit Nijmegen, where she continues her research and development in immunology. Her work has garnered attention for its potential applications in therapeutic settings.

Collaborations

Yvette has collaborated with notable colleagues such as Carl Gustav Figdor and Ruurd Torensma, contributing to advancements in her field.

Conclusion

Yvette Van Kooyk's innovative work in immunology, particularly her patents on dendritic cell-T cell interactions, showcases her commitment to advancing medical science. Her contributions have the potential to significantly impact the treatment of various immune-related conditions.